Ionis Pharmaceuticals Inc (IONS)
38.76
+0.34
(+0.87%)
USD |
NASDAQ |
Nov 05, 16:00
38.76
0.00 (0.00%)
After-Hours: 16:10
Ionis Pharmaceuticals Cash from Operations (Quarterly): -119.88M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -119.88M |
| March 31, 2024 | -149.94M |
| December 31, 2023 | 32.86M |
| September 30, 2023 | -109.02M |
| June 30, 2023 | -97.36M |
| March 31, 2023 | -133.99M |
| December 31, 2022 | -200.20M |
| September 30, 2022 | -24.43M |
| June 30, 2022 | -18.10M |
| March 31, 2022 | -31.65M |
| December 31, 2021 | 203.69M |
| September 30, 2021 | -55.57M |
| June 30, 2021 | -62.65M |
| March 31, 2021 | -54.66M |
| December 31, 2020 | 97.98M |
| September 30, 2020 | -10.28M |
| June 30, 2020 | -44.22M |
| March 31, 2020 | -7.592M |
| December 31, 2019 | 277.84M |
| September 30, 2019 | -12.81M |
| June 30, 2019 | -27.11M |
| March 31, 2019 | 107.70M |
| December 31, 2018 | 115.51M |
| September 30, 2018 | -26.00M |
| June 30, 2018 | 500.24M |
| Date | Value |
|---|---|
| March 31, 2018 | 13.16M |
| December 31, 2017 | 20.40M |
| September 30, 2017 | 28.72M |
| June 30, 2017 | 2.363M |
| March 31, 2017 | 122.66M |
| December 31, 2016 | -26.84M |
| September 30, 2016 | 24.29M |
| June 30, 2016 | -33.78M |
| March 31, 2016 | -75.77M |
| December 31, 2015 | -37.47M |
| September 30, 2015 | 36.22M |
| June 30, 2015 | 65.21M |
| March 31, 2015 | -42.83M |
| December 31, 2014 | 70.68M |
| September 30, 2014 | 1.944M |
| June 30, 2014 | -34.02M |
| March 31, 2014 | -32.33M |
| December 31, 2013 | -14.49M |
| September 30, 2013 | 65.82M |
| June 30, 2013 | 22.74M |
| March 31, 2013 | -10.58M |
| December 31, 2012 | 36.04M |
| September 30, 2012 | -24.87M |
| June 30, 2012 | -2.577M |
| March 31, 2012 | -6.711M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-200.20M
Minimum
Dec 2022
277.84M
Maximum
Dec 2019
-26.69M
Average
-44.22M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
| Biogen Inc | 935.60M |
| Alnylam Pharmaceuticals Inc | 43.71M |
| Biomarin Pharmaceutical Inc | 221.48M |
| Rigel Pharmaceuticals Inc | 0.302M |
| Apellis Pharmaceuticals Inc | -8.339M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 62.45M |
| Cash from Financing (Quarterly) | 2.557M |
| Free Cash Flow | -375.18M |
| Free Cash Flow Per Share (Quarterly) | -0.9601 |
| Free Cash Flow to Equity (Quarterly) | -141.63M |
| Free Cash Flow to Firm (Quarterly) | -117.33M |
| Free Cash Flow Yield | -6.69% |